Rapid Micro Biosystems, Inc. (RPID) Misses Q1 EPS by 2c ; Offers Guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q1 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $6.6 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2025 revenue of ~$32 million, versus the consensus of $32.55 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• TDAC shareholders vote to extend SPAC, keeping $156.8M in trust
• Labcorp makes RNA-based colorectal cancer home test available nationwide